Growth Hormone Treatment in Short Children Born Small for Gestational Age

• Status: Completed
• Trial end date: 2007-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparison of 2 different doses of human growth hormone treatment on change in height after 1 and 2 years of treatment.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Hormones

Criteria

Inclusion Criteria:

• Born small for gestational age

• actual body height less than or equal -3 SDS

• chronological age greater than 3 years

Exclusion Criteria:

• Growth hormone deficiency

• any defined syndromal disease

• Diabetes mellitus